Peng Yuan

IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor

Yuying Liu, Nannan Zhou, Li Zhou et al. · Nature Immunology · 2021 · 346 citations

Inflammation, Cancer Immunosurveillance, Aryl Hydrocarbon Receptor +11

Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning

Jialiang Yang, Jie Ju, Lei Guo et al. · Computational and Structural Biotechnology Journal · 2021 · 213 citations · Full text

Convolutional Neural Network, Stain Normalization, Engineering +24

RC48-ADC, a HER2-targeting antibody-drug conjugate, in patients with HER2-positive and HER2-low expressing advanced or metastatic breast cancer: A pooled analysis of two studies.

Jiayu Wang, Yunjiang Liu, Qingyuan Zhang et al. · Journal of Clinical Oncology · 2021 · 102 citations

Breast Oncology, Immunology, Immunotherapeutics +18

Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial

Pin Zhang, Yi Yin, Hongnan Mo et al. · Oncotarget · 2016 · 95 citations · Full text

Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM

Hongming Miao, Juanjuan Ou, Peng Yuan et al. · Nature Communications · 2016 · 93 citations · Full text